Technical Analysis for NSPR - InspireMD, Inc.
| ADX | Long-Term | Intermediate-Term | Short-Term |
|---|---|---|---|
| Weak or Absent | Down | Down | Down |
| See historical NSPR trend table... | |||
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Slingshot Bearish | Bearish Swing Setup | 0.00% | |
| Stochastic Buy Signal | Bullish | 0.00% | |
| Lower Bollinger Band Walk | Weakness | 0.00% | |
| Wide Bands | Range Expansion | 0.00% | |
| Oversold Stochastic | Weakness | 0.00% | |
| Spinning Top | Other | 2.45% | |
| NR7 | Range Contraction | 2.45% | |
| Lower Bollinger Band Walk | Weakness | 2.45% | |
| New 52 Week Low | Weakness | 2.45% | |
| Wide Bands | Range Expansion | 2.45% |
Free Daily (Stock) Chart Reading
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 05/14/2019
- Sector: Healthcare
- Industry: Medical Devices
InspireMD Inc., a medical device company, focuses on the development and commercialization of proprietary MGuard stent platform technology. Its lead products include MGuard stent, an embolic protection device based on a protective sleeve, which is constructed out of an ultra-thin polymer mesh and wrapped around the stent; and MGuard Prime, which include its mesh sleeve wrapped around a cobalt-chromium stent. The company markets its products for use primarily in patients with acute coronary syndromes, notably acute myocardial infarction (heart attack), and saphenous vein graft coronary interventions (bypass surgery). It sells its products through distributors in Europe, southeast Asia, India, and Latin America. InspireMD Inc. was founded in 2005 and is headquartered in Tel Aviv, Israel.
Medicine Medical Specialties Medical Devices Interventional Radiology Circulatory System Interventional Cardiology Stent Acute Coronary Syndrome Acute Coronary Syndromes Heart Attack Percutaneous Coronary Intervention
Medicine Medical Specialties Medical Devices Interventional Radiology Circulatory System Interventional Cardiology Stent Acute Coronary Syndrome Acute Coronary Syndromes Heart Attack Percutaneous Coronary Intervention
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength | |||
| Summary: | Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies. | ||
See more NSPR news...
Indicators
| Indicator | Value |
|---|---|
| 52 Week High | 82.0 |
| 52 Week Low | 3.0536 |
| Average Volume | 341,164 |
| 200-Day Moving Average | 8.8492 |
| 50-Day Moving Average | 5.526 |
| 20-Day Moving Average | 4.4 |
| 10-Day Moving Average | 4.017 |
| Average True Range | 0.6085 |
| ADX | 19.12 |
| +DI | 24.2479 |
| -DI | 25.4356 |
| Chandelier Exit (Long, 3 ATRs ) | 5.6845 |
| Chandelier Exit (Short, 3 ATRs ) | 4.8791 |
| Upper Bollinger Band | 5.8073 |
| Lower Bollinger Band | 2.9927 |
| Percent B (%b) | 0.13 |
| BandWidth | 63.968182 |
| MACD Line | -0.5698 |
| MACD Signal Line | -0.4721 |
| MACD Histogram | -0.0977 |
| Fundamentals | Value |
|---|---|
| Market Cap | 24.96 Million |
| Num Shares | 7.45 Million |
| EPS | -2.45 |
| Price-to-Earnings (P/E) Ratio | -1.37 |
| Price-to-Sales | 1.52 |
| Price-to-Book | 0.53 |
| PEG Ratio | 0.00 |
| Dividend | 0.00 |
| Dividend Yield | 0.00% |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 3.97 | ||||
| Resistance 3 (R3) | 3.98 | 3.78 | 3.86 | ||
| Resistance 2 (R2) | 3.78 | 3.63 | 3.78 | 3.83 | |
| Resistance 1 (R1) | 3.57 | 3.53 | 3.56 | 3.56 | 3.80 |
| Pivot Point | 3.37 | 3.37 | 3.37 | 3.37 | 3.37 |
| Support 1 (S1) | 3.16 | 3.21 | 3.14 | 3.14 | 2.90 |
| Support 2 (S2) | 2.96 | 3.12 | 2.96 | 2.87 | |
| Support 3 (S3) | 2.74 | 2.96 | 2.84 | ||
| Support 4 (S4) | 2.73 |
